Circulating tumor cells (CTCs) are vital components of liquid biopsies for diagnosis of
residual cancer, monitoring of therapy response, and prognosis of recurrence. Scientific …

The prognostic role of circulating tumor cells (CTCs) has been clearly demonstrated in many
types of cancer. However, their roles in diagnostic and treatment strategies remain to be …

The mutational and phenotypic landscape of tumors is dynamic, requiring constant
monitoring of cancer patients to provide the most up-to-date and effective care. Circulating …

Abstract The CellSearch® system (CS) enables standardized enrichment and enumeration
of circulating tumor cells (CTCs) that are repeatedly assessable via non-invasive “liquid …

Pancreatic cancer (PC) is one of the most common malignancies. Surgical resection is a
potential curative approach for PC, but most patients are unsuitable for operations when at …

EpCAM expressing circulating tumor cells, detected by CellSearch, are predictive of short
survival in several cancers and may serve as a liquid biopsy to guide therapy. Here we …

Background Cisplatin and gemcitabine is the standard first-line chemotherapy regimen for
patients with advanced biliary tract cancer; expression of VEGF and its receptors is …

Circulating Tumor Cells (CTCs) are cancer cells that split away from the primary tumor and
appear in the circulatory system as singular units or clusters, which was first reported by Dr …

Circulating tumor cells (CTCs) from peripheral blood hold important information for cancer
diagnosis and disease monitoring. Analysis of this “liquid biopsy” holds the promise to usher …

The release of circulating tumor cells (CTCs) into vasculature is an early event in the
metastatic process. The analysis of CTCs in patients has recently received widespread …